CRO Pharma NY is a pharmaceutical lab located in New York, New York, specializing in providing comprehensive contract research services. Situated at 133 Charles Street in the 10014 postal area, this facility supports various stages of pharmaceutical development, including analytical testing, formulation, and quality control. The lab’s location in a major urban center allows it to serve a diverse client base within the pharmaceutical and biotechnology industries.
The laboratory is equipped to handle a wide range of pharmaceutical testing needs, focusing on precision and adherence to industry standards. Its operations include method development, stability studies, and product characterization, all essential for ensuring the safety and efficacy of pharmaceutical products. CRO Pharma NY works with formulations at different stages of development, supporting research teams with detailed data and technical expertise.
In addition to analytical testing, the lab also facilitates regulatory support by generating documentation and data critical for product approvals and compliance. The staff comprises trained professionals who manage complex projects with attention to detail and scientific rigor. This enables CRO Pharma NY to contribute valuable insights that aid in the advancement of pharmaceutical compounds from early research to market readiness.
By maintaining a strong commitment to quality and accuracy, CRO Pharma NY plays a key role in the pharmaceutical research landscape of New York City. Its services provide essential support to companies looking to develop innovative therapies and maintain regulatory compliance, making it a vital partner in the local pharmaceutical ecosystem.
